JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells
about
Novel strategies to target the ubiquitin proteasome system in multiple myelomaNitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeuticsAdaptive responses of androgen receptor signaling in castration-resistant prostate cancerStilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cellsJS-K promotes apoptosis by inducing ROS production in human prostate cancer cellsJS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cellsGlutathione S-conjugates as prodrugs to target drug-resistant tumors.Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer.A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells.Glutathione Transferase (GST)-Activated Prodrugs.The yin and yang of nitric oxide in cancer progression.miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin.Endothelial NO Synthase-Dependent S-Nitrosylation of β-Catenin Prevents Its Association with TCF4 and Inhibits Proliferation of Endothelial Cells Stimulated by Wnt3a.Glutathione S -transferase π: a potential role in antitumor therapy
P2860
Q26773246-FD03617A-57FA-4340-AB0F-E522DA39F788Q26782525-39EAC473-BC23-4F23-B32E-D8B2136B1481Q26795625-95A3F570-46FE-4424-B997-D4CC211526E1Q28539233-4D4DCA5B-D005-41C7-88FD-2A9F79293E5AQ33598148-E0EE733D-1128-4887-8563-A6F112C08ECEQ33733592-05DCE70A-726F-4A41-8F1F-D510A15A5BEBQ34024771-88775769-CA96-447F-9434-98B1860332F9Q35568239-D403ABA6-4D55-4DC0-BCBF-D1884A337B30Q36149908-811B95C9-A8A0-4CD1-A700-66673871EE1FQ37327903-BB762641-27E2-490D-B9FF-8074EA639F72Q38077081-BAC4E08F-C50F-4546-8523-0E0054ECDACBQ38096240-7D467126-BD02-4EB2-AE87-BAAE98A470B3Q38700491-BFC0D9E6-F5D0-47B4-9954-79D899C113A9Q38892465-5573C015-1E9D-41D6-87EC-9DEC984B14E1Q58694500-633BF95C-C758-4E18-BDDF-0B384E1EB2AE
P2860
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
JS-K, a glutathione/glutathion ...... aling in prostate cancer cells
@ast
JS-K, a glutathione/glutathion ...... aling in prostate cancer cells
@en
JS-K, a glutathione/glutathion ...... aling in prostate cancer cells
@nl
type
label
JS-K, a glutathione/glutathion ...... aling in prostate cancer cells
@ast
JS-K, a glutathione/glutathion ...... aling in prostate cancer cells
@en
JS-K, a glutathione/glutathion ...... aling in prostate cancer cells
@nl
prefLabel
JS-K, a glutathione/glutathion ...... aling in prostate cancer cells
@ast
JS-K, a glutathione/glutathion ...... aling in prostate cancer cells
@en
JS-K, a glutathione/glutathion ...... aling in prostate cancer cells
@nl
P2093
P2860
P356
P1433
P1476
JS-K, a glutathione/glutathion ...... aling in prostate cancer cells
@en
P2093
Andrea Hessenauer
Andres J Schrader
Klaus-Dieter Spindler
Marcus V Cronauer
Mark Schrader
Martin Laschak
Wolfgang Streicher
P2860
P2888
P356
10.1186/1471-2407-12-130
P407
P577
2012-03-30T00:00:00Z
P5875
P6179
1028671494